4:14 PM ET
Form 4
Insider Selling
Maze Therapeutics CEO Jason V. Coloma Sells $1.04M of Stock
Jason V. Coloma, CEO, sold 34,501 shares of Maze Therapeutics, Inc. at $30.09 to $31.05 a share (average $30.25) in 4 transactions, worth $1.04M in total on Nov 2, 2026. Shares held after the trade: 186,901 (-2.8%).
- Value
- $1.04M
- Shares
- 34,501
- Average price
- $30.25
- Role
- CEO
- Holding change
- -2.8%
- Trade date
- Nov 2, 2026